Walgreens Boots Alliance's shares surged over 25% after exceeding investor expectations with Q1 fiscal 2025 adjusted EPS of 51 cents and revenues of $39.46 billion.
Despite the EPS and revenue being lower compared to the year-ago quarter, the 7.5% year-over-year revenue increase and the company beating analysts' predictions suggest a potential turnaround.
The company's substantial Q1 operating loss of $245 million, attributed partially to a store optimization plan that includes closing 1,200 locations, highlights ongoing challenges.
Inflationary pressures and falling reimbursement rates for prescription drugs have led to cautious consumer spending, impacting Walgreens' performance despite recent improvements in EPS and revenue.
Collection
[
|
...
]